approval
saveDYANAVEL XR (AMPHETAMINE) — FDA approval
community read0 votes
Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalAMPHETAMINE SULFATE — FDA approvalSep 26, 2025 · 369d ago
- approvalAMPHETAMINE SULFATE — FDA approvalSep 26, 2025 · 369d ago
- approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalSep 23, 2025 · 372d ago
- approvalAMPHETAMINE SULFATE — FDA approvalOct 17, 2023 · 1079d ago
- approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalOct 13, 2023 · 1083d ago
- approvalAMPHETAMINE SULFATE — FDA approvalOct 13, 2023 · 1083d ago
- approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalJun 1, 2022 · 1582d ago
- approvalAMPHETAMINE SULFATE — FDA approvalFeb 25, 2022 · 1678d ago
same company · ±60 days · 6
- approvalADZENYS XR-ODT (AMPHETAMINE) — FDA approvalJan 4, 2017
- approvalTUZISTRA XR: TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalJan 13, 2017
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 16, 2016
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 16, 2016
- approvalTUZISTRA XR: TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalFeb 17, 2017
- approvalADZENYS XR-ODT (AMPHETAMINE) — FDA approvalNov 18, 2016
comments(0)
5-min edit window · permanent after that